Adial Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 68.85 K | $43.66 K | 11.32% | 0.37% |
MANCHESTER CAPITAL MANAGEMENT LLC | 05/09/2025 | 48.10 K | $30.50 K | 0.00% | 0.26% |
UBS GROUP AG | 05/13/2025 | 47.75 K | $30.27 K | 127.16% | 0.26% |
BLACKROCK, INC. | 05/02/2025 | 27.77 K | $17.61 K | 0.00% | 0.15% |
VIRTU FINANCIAL LLC | 05/12/2025 | 26.41 K | $17.00 K | 100.00% | 0.14% |
VANGUARD GROUP INC | 05/09/2025 | 13.16 K | $8.34 K | 100.00% | 0.07% |
1620 INVESTMENT ADVISORS, INC. | 05/14/2025 | 3.60 K | $2.28 K | 0.00% | 0.02% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 1.43 K | $905 | 123.67% | 0.01% |
05/02/2025 | 927 | $588 | -1.07% | 0.01% | |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 160 | $101 | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 55 | $35 | 5.77% | 0.00% |
ABOUND WEALTH MANAGEMENT | 04/17/2025 | 27 | $18 | 0.00% | 0.00% |
MORGAN STANLEY | 05/15/2025 | 9 | $6 | 0.00% | 0.00% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 04/22/2025 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Adial Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 18 institutional investors and hedge funds held shares of Adial Pharmaceuticals, Inc.. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 68,850
Manchester Capital Management LLC: 48,097
UBS Group AG: 47,745
BlackRock, Inc.: 27,770
Virtu Financial LLC: 26,414
VANGUARD GROUP INC: 13,159
1.28% of Adial Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 280.98 K shares in the last 24 months. This purchase volume represents approximately $126.02 K in transactions.